ArticleCells2023

Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas.

Kristen D Pawlowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.